Dis-Chem accelerates healthcare transformation strategy
Dis-Chem Pharmacies Limited reported higher revenue for the financial year ended 28 February 2026, supported by stronger retail and wholesale trading, even as headline earnings declined due to investment spending and prior-year gains.
Staff Writer Dis-Chem Pharmacies Limited reported higher revenue for the financial year ended 28 February 2026, supported by stronger retail and wholesale trading, even as headline earnings declined due to investment spending and prior-year gains. The group’s revenue increased by 9.3% to N$42.8 billion, driven by growth across its retail and wholesale divisions in an environment where consumers remained under financial pressure. Dis-Chem operates multiple stores in Namibia, offering a wide range of health, wellness, and beauty products.
The stores are situated in Windhoek, Swakopmund, and Walvis Bay. Retail revenue rose 9% to N$34 billion, supported by both internal supply to Dis-Chem stores and growth in external pharmacy clients. Despite the top-line growth, earnings declined.
